Procter & Gamble Co vs Direxion NASDAQ 100 Equal Weighted Index Shares — how do they compare? Procter & Gamble Co trades at $151.23 (market cap $349.77B), while Direxion NASDAQ 100 Equal Weighted Index Shares trades at $121.92 (market cap $1.45B). The key difference: Procter & Gamble Co is far larger — about 241.2× Direxion NASDAQ 100 Equal Weighted Index Shares's market cap, and Procter & Gamble Co pays a 2.89% dividend while Direxion NASDAQ 100 Equal Weighted Index Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Procter & Gamble Co for 131 Days and Direxion NASDAQ 100 Equal Weighted Index Shares for 48 Days on average.
| PG | QQQE | |
|---|---|---|
Market Cap | $349.77B | $1.45B |
Volume | 10,055,825 | 323,568 |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $167.18 | $124.69 |
52-Week Low | $138.10 | $96.06 |
Typical Hold Time | 131 Days | 48 Days |
Enterprise Value | $375.61B | — |
Dividend Yield | 2.89% | — |
Signals from Pluang's Aura AI — not financial advice
Procter & Gamble (PG) trades at $150.59, up 1.87% with bullish technical momentum as it approaches resistance near $151. The company demonstrates strong fundamentals with consistent earnings beats, 18.44% net margins, and robust cash flow generation. Recent partnership with the WNBA highlights strategic brand expansion while maintaining a 69-year dividend growth streak. Valuation metrics show premium multiples relative to peers, with P/E at 22.75 and P/S at 4.19.
PG offers stable growth with dividend reliability but faces valuation concerns amid modest revenue expansion. The consensus price target of $160.13 suggests 6.3% upside potential, supported by 53 analyst ratings favoring Buy (52.8%). Key risks include premium valuation pressure and competitive market dynamics. The stock presents a defensive investment opportunity with consistent cash flow generation in consumer staples.
QQQE, the Direxion NASDAQ-100 Equal Weighted Index ETF, trades at $121.03, down 0.71% on the day. The technical outlook is bullish based on moving averages, with oscillators neutral. Recent news highlights its equal-weight strategy reducing technology concentration compared to market-cap weighted peers. The fund provides diversified exposure to large-cap growth stocks within the Nasdaq-100 index.
The outlook for QQQE is supported by its tactical appeal as an equal-weight alternative, though it carries risks tied to Nasdaq performance and sector concentration. Investor sentiment appears cautiously optimistic given recent favorable coverage comparing it to QQQ. The absence of traditional valuation ratios is typical for an ETF tracking an index.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →QQQE is an ETF that seeks to track the performance of the NASDAQ-100 Equal Weighted Index. Unlike traditional market-capitalization-weighted indexes, this fund assigns equal weight to each of the 100 non-financial companies in the NASDAQ-100 and rebalances quarterly. This equal-weighting scheme reduces concentration risk in the largest technology companies and increases the fund's exposure to smaller-cap and mid-cap companies within the index, providing a differentiated growth profile.
Read more on QQQE →